“Endocannabinoids may modify cancer development, progression and associated pain.
We determined whether cancer-evoked dysregulations in this system become manifest in altered tissue and plasma endocannabinoids…
The endocannabinoid system was subject to cancer-associated regulations to an extent that led to measurable changes in circulating endocannabinoid levels, emphasizing the importance of the endocannabinoid system in the pathophysiology of cancer.”